Search Results for "Factor Viii Levels Massive Haemorrhage"
Original Source: Changes in the levels of factor VIII and von Willebrand factor in the puerperium.
Summary. To determine changes in Factor VIII (FVIII) and von Willebrand Factor (VWF) in the first 3 days of the puerperium. A prospective study assessing FVIII clotting activity, VWF activity and antigen levels in 95 women (with singleton uncomplicated pregnancies) during labour and on days 1, 2 and 3 of the puerperium. There were no significant differences in FVIII, VWF:Ag and VWF:CB on days 1 and 2 of the puerperium compared with levels during labour. There was a significant decrease in VWF:Ag (P =...
Matching Channels
Matching News
Plasma-Derived Factor VIII Has No Immunogenic Advantage (CME/CE)
(MedPage Today) -- Factor VIII clotting factors derived from donor plasma were just as likely as recombinant products to induce inhibitory antibodies in children with hemophilia A, researchers said.
[Review] Intracerebral haemorrhage: mechanisms of injury and therapeutic targets
Intracerebral haemorrhage accounts for about 10–15% of all strokes and is associated with high mortality and morbidity. No successful phase 3 clinical trials for this disorder have been completed. I...
Inhibitor development risk similar for factor VIII products
(HealthDay)—For children with severe hemophilia A, the risk of inhibitor development is similar with plasma-derived and recombinant factor VIII products and is not affected by von Willebrand factor...
Smoking, high blood pressure and cholesterol can be fatal for haemorrhage survivors, study finds
A Finnish study shows that patients who have experienced subarachnoid haemorrhage (SAH) have a highly increased risk of death due to a stroke or cerebral haemorrhage, and have double the mortality rat...
Pfizer to transfer Factor VIII license to Russia's Biocad; Pharm-sintez cancer plans
US drug behemoth Pfizer (NYSE: PFE) is finalizing confidions for the transfer of a license for the production of Factor VIII, which is used to treat hemophilia to Biocad, one of Russia's leading biote...
Study finds primary factors that increase risk of mortality in subarachnoid haemorrhage survivors
"It is particularly important for subarachnoid haemorrhage survivors to refrain from smoking and to take care of their blood pressure and cholesterol levels; apart from age, these are the primary fact...
Trial to assess the benefits of partial Factor VIII inhibition in total hip replacement surgery patients Lund, Sweden and Leuven, Belgium – 27 April 2011 – BioInv...
Baxter partners with Hemobrás for hemophilia A
Baxter International announced an exclusive 20-year partnership with Hemobrás to provide hemophilia patients in Brazil greater access to recombinant factor VIII therapy for the treatment of hemophili...
Matching PubMed Articles
Case of acquired hemophilia with factor VIII inhibitor in a mother and newborn.
We report a mother and newborn in the puerperium with hemorrhage secondary to factor VIII inhibitor. A 31-year-old gravida 1 para 1 delivered at a local clinic with a massive postpartum hemorrhage. Th...
Principles of care for the diagnosis and treatment of von Willebrand disease.
Von Willebrand disease is a common autosomal inherited bleeding disorder caused by quantitative or qualitative defects of von Willebrand factor, a multi-adhesive protein that binds platelets to expose...
Membrane binding properties of the factor VIII C2 domain.
Factor VIII functions as a cofactor for factor IXa in a membrane-bound enzyme complex. Membrane binding accelerates activity of the factor VIIIa-factor IXa complex approximately 100,000-fold and the m...
An unusual case of massive subcutaneous chest wall haemorrhage with enoxaparin.
Enoxaparin is used in the treatment of acute coronary syndromes and offers improved outcome in the composite endpoint of death, myocardial infarction and major bleeding when compared with unfractionat...
Hemophilia a in cardiac operations: a model of reduced thrombin generation.
Patients with hemophilia A have a congenital defect in thrombin generation. Only limited data are available on the substitution regimens in hemophilia A patients during and after cardiac operations. T...
